The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 2.19 million shares were traded. NEO stock price reached its highest trading level at $11.93 during the session, while it also had its lowest trading level at $11.415.
Ratios:
We take a closer look at NEO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.91. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.48.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’25 when Olivo Alicia C sold 20,916 shares for $12.00 per share. The transaction valued at 250,992 led to the insider holds 31,083 shares of the business.
ALICIA OLIVO bought 11,939 shares of NEO for $138,612 on Nov 25 ’25. On Oct 16 ’25, another insider, ALICIA OLIVO, who serves as the Officer of the company, bought 4,918 shares for $9.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1521600512 and an Enterprise Value of 1767791488. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15 while its Price-to-Book (P/B) ratio in mrq is 1.81. Its current Enterprise Value per Revenue stands at 2.493 whereas that against EBITDA is -513.445.
Stock Price History:
The Beta on a monthly basis for NEO is 1.57, which has changed by -0.33521765 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $4.72. The 50-Day Moving Average of the stock is 5.00%, while the 200-Day Moving Average is calculated to be 35.27%.
Shares Statistics:
According to the various share statistics, NEO traded on average about 3.13M shares per day over the past 3-months and 1710930 shares per day over the past 10 days. A total of 128.89M shares are outstanding, with a floating share count of 123.12M. Insiders hold about 4.84% of the company’s shares, while institutions hold 97.06% stake in the company. Shares short for NEO as of 1765756800 were 8374376 with a Short Ratio of 2.67, compared to 1763078400 on 8416654. Therefore, it implies a Short% of Shares Outstanding of 8374376 and a Short% of Float of 8.92.
Earnings Estimates
Its stock is currently analyzed by 12.0 different market analysts. The consensus estimate for the next quarter is $0.01, with high estimates of $0.06 and low estimates of -$0.04.
Analysts are recommending an EPS of between $0.11 and $0.08 for the fiscal current year, implying an average EPS of $0.1. EPS for the following year is $0.18, with 12.0 analysts recommending between $0.3 and $0.06.
Revenue Estimates
According to 12 analysts,. The current quarter’s revenue is expected to be $187.92M. It ranges from a high estimate of $188.83M to a low estimate of $186.6M. As of. The current estimate, Neogenomics Inc’s year-ago sales were $172MFor the next quarter, 12 analysts are estimating revenue of $187.41M. There is a high estimate of $194.32M for the next quarter, whereas the lowest estimate is $183M.
A total of 13 analysts have provided revenue estimates for NEO’s current fiscal year. The highest revenue estimate was $725.99M, while the lowest revenue estimate was $723.3M, resulting in an average revenue estimate of $724.94M. In the same quarter a year ago, actual revenue was $660.57MBased on 13 analysts’ estimates, the company’s revenue will be $795.92M in the next fiscal year. The high estimate is $807.13M and the low estimate is $784.8M.
